CD274 and cancer: Cox proportional hazards model adjusted for cancer group (lymphoma versus solid tumors) indicated improved PFS for patients with samples categorized as PD-L1 high versus low/no expression (HR 0.12, 95% CI 0.02–0.8, P = 0.03; Fig. 3B).